# Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

> **NCT05276401** · PHASE2 · TERMINATED · sponsor: **Lakewood-Amedex Inc** · enrollment: 3 (actual)

## Conditions studied

- Chronic Diabetic Foot Ulcers

## Interventions

- **DRUG:** 5% Bisphosphocin Topical Gel
- **DRUG:** Placebo Topical Gel
- **DRUG:** 10% Bisphosphocin Topical Gel

## Key facts

- **NCT ID:** NCT05276401
- **Lead sponsor:** Lakewood-Amedex Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-03-11
- **Primary completion:** 2022-05-18
- **Final completion:** 2022-06-15
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Request for additional preclinical data.
- **Last updated:** 2024-01-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05276401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05276401, "Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05276401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*